Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Retina
Glaucoma
Cornea
 
 
Survey

Do you use anti-VEGF therapy in infants?

Yes
40%
No
60%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.


July 30, 2014
Increased AMD risk
Vasodilators and beta-blockers increase AMD risk
Vasodilators and oral beta-blockers are associated with an increase in the hazard of incidence of early age-related macular degeneration (AMD) and exudative AMD, respectively, according to research recently published online. More...
Acute glaucoma
Acute glaucoma is an inflammatory disease
Acute glaucoma in mice is largely an inflammatory disease, and high intraocular pressure (IOP) causes vision loss by starting an inflammatory response similar to that caused by bacterial infections. More...
Aganirsen drops
Aganirsen drops inhibit neovascularization
Aganirsen eye drops inhibited corneal neovascularization in patients with keratitis and reduced the need for transplantation in patients who have viral keratitis and central neovascularization, according to a Phase III study of 69 patients. More...
Event Profile
14th EVRS Congress
Dates: 4th to 7th September 2014
Venue: Edifício da Alfândega, PORTO – PORTUGAL
The EVRS philosophy will guide the meeting throughout. In contrast to many other congresses, EVRS has decided not to allow any presentations created by the industry, the only exception being special and clearly designated industry symposia.
Read more:
Products in Practice Issue 3
Real world experience of leading ophthalmic products. Read more:
Ranibizumab leading the anti-VEGF evolution
Considerations and new perspectives in anti-VEGF therapy. Read more: